Abstract:Significance Cdc48/TERA/p97/VCP is an enzyme that utilizes energy stored in ATP to coordinate protein degradation and recycling in eukaryotic cells. Point mutations in p97 cause a degenerative disease in humans that affects the central nervous system, bone, and muscle. These mutations deregulate the structure and dynamics of p97 with implications for binding of a cofactor that recruits p97 to the lysosomal degradation pathway. Here we probe the plasticity of p97, searching for hotspots in this enzyme to revert the effect of disease mutations. We demonstrate that mutations at secondary sites can shift the dynamics and structure toward wild type, highlighting the potential of exploiting the plasticity of p97 in the rational design of compounds that restore function in disease mutants. p97/VCP, a member of the AAA+ (ATPases associated with diverse cellular activities) family of proteins, is implicated in the etiology of a group of degenerative diseases affecting bone and muscle tissue as well as the central nervous system. Methyl-TROSY–based NMR studies have previously revealed how disease-causing mutations deregulate a subtle dynamic conformational equilibrium involving the N-terminal domain (NTD) with implications for the binding of certain adaptors, providing insight into how disease mutations lead to abnormal function. Herein the conformational plasticity of the p97 system is explored in an attempt to identify hotspots that can serve as targets for restoring function in disease mutants by shifting the position of the NTD back to its wild-type location. Although p97 is overall robust with respect to extensive mutagenesis throughout the protein involving conservative substitutions of hydrophobic residues, key positions have been identified that alter the NTD equilibrium; these lie in specific regions that localize to the interface between the NTD and the D1 nucleotide-binding domain of the complex. Notably, for a severe disease mutant involving an R155C substitution the NTD equilibrium can be shifted back to its wild-type position by mutation at a secondary site with restoration of wild-type two-pronged binding of the UBXD1 adaptor protein that is impaired in disease; this underlies the potential for recovering function by targeting p97 disease mutants with drug molecules.

Best-First Search Algorithm for Solving HP Lattice Model

Folding Lattice HP Model of Proteins Using the Bond-Fluctuation Model

A HNP LATTICE MODEL OF PROTEINS

A filter-and-fan approach to the 2D HP model of the protein folding problem

STUDY OF NATIVE CONFORMATIONS AND THERMODYNAMIC PROPERTIES OF TWO-DIMENSIONAL HP COMPACT POLYMERS

Annealing Genetic Algorithm for Protein Folding Simulations in the 3D HP Model

Flame Holding : Selected Engine Combustion Problems 99 FLAME SPREADING FROM BLUFF-BODY FLAMEHOLDERS

Hysteretic Optimization for the 3D Protein Folding Based on the Lattice Model

Folding lattice proteins with quantum annealing

FoldingZero: Protein Folding from Scratch in Hydrophobic-Polar Model

Protein Folding Simulations of the Hydrophobic–hydrophilic Model by Combining Tabu Search with Genetic Algorithms

Protein folding optimization based on 3D off-lattice model via an improved artificial bee colony algorithm

Equivalence Classes of Optimal Structures in HP Protein Models Including Side Chains

Local Rules for Protein Folding on Triangular Lattice in the 2 D HP Model

Fast Tree Search For Enumeration Of A Lattice Model Of Protein Folding

A combined steepest descent and genetic algorithm (SD/GA) approach for the optimization of solvation parameters

An approach to solve the coarse-grained Protein folding problem in a Quantum Computer

Using quantum annealing to design lattice proteins

Exploiting conformational plasticity in the AAA+ protein VCP/p97 to modify function

Generic folding and transition hierarchies for surface adsorption of hydrophobic-polar lattice model proteins

Monte Carlo Sampling of Protein Folding by Combining an All-Atom Physics-Based Model with a Native State Bias